The Safety and Efficacy of ECMO in the Management of Patients With Respiratory Failure

NCT07800325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-09-02

No results posted yet for this study

Summary

Evaluation of the efficacy and safety of the Rengine extracorporeal cardiopulmonary support system and the ECMO sterile oxygenator in the management of respiratory failure.

Conditions

  • Respiration Failure

Interventions

OTHER

ECMO

Using ECMO in the management of respiratory failure

Sponsors & Collaborators

  • Life Shield Medical Technology Co., LTD

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2026-04-04
Completion
2026-04-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07800325 on ClinicalTrials.gov